Medacta Aktie

180,80 EUR -0,60 EUR -0,33 %

09.01.2026

BMN

168,00 CHF -0,60 CHF -0,36 %

09.01.2026

SWX

Medacta jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)

Jetzt loslegen

Direkt handeln

Bei einem anderen Broker handeln

KGV30,58Div. Rendite0,65%

WKNMED777

ISINCH0468525222

SymbolMEDGF

Medacta Aktien News

Sortieren:Datum Meistgelesen

08.09.25EQS GroupMedacta Group SA reports surge in adjusted EBITDA margin to 29.6% in constant currency in H1 2025

31.07.25EQS GroupMedacta Group SA reports continued above-market revenue growth of 19.8% in constant currency in H1 2025 and upgrades its FY 2025 and mid-term guidance

07.05.25EQS GroupMedacta announces the results of today's Annual General Meeting

WerbungMedacta-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero

08.04.25EQS GroupMedacta publishes 2025 Annual General Meeting invitation

25.03.25EQS GroupMedacta Group SA: Medacta Group SA reports an excellent performance in 2024 with an adjusted EBITDA margin1 in constant currency of 28.0%

07.03.25EQS GroupMedacta Group SA acquires Parcus Medical to accelerate expansion in Sportsmed

04.02.25EQS GroupMedacta Group SA reports significant above-market revenue growth of 16.2% in constant currency in 2024

21.10.24EQS GroupMedacta unveils the extended enhancements to its Hip Revision Platform

30.09.24EQS GroupMedacta Hosts Inaugural Capital Markets Day, Showcasing Responsible Innovation and Effective Growth Strategy

25.09.24EQS GroupMedacta Group SA reports revenue growth of 14.3% at constant currency and adjusted EBITDA margin 26.9%, or 28.1% at constant currency in 1H 2024.

24.09.24EQS GroupMedacta NextAR Rod Optimizer, a Disruptive Technology Redefining Rod Management in Spine Surgery, wins the 2024 Spine Technology Award from Orthopedics This Week

12.09.24EQS GroupMedacta Introduces a Simplified Approach for the M-ARS ACL Technique at the AGA Congress 2024, Mimicking the Native Ligament Footprint with an Optimized Surgical Flow

29.08.24EQS GroupMedacta Enters Partnership with THINK Surgical for Robotic Total Knee Arthroplasty Solution

28.08.24EQS GroupMighty Oak Medical and Medacta Announce Non-Exclusive Worldwide License of Patents for Patient-Specific Pedicle Screw Guides

24.07.24EQS GroupMedacta Group SA: Medacta Group SA revenues grew 14.3% at constant currency in 1H 2024

30.05.24EQS GroupMedacta 25th Anniversary World Tour continues with events in Australia and the United States focusing on Personalized and Sustainable Total Knee Arthroplasty

07.05.24EQS GroupMedacta announces the results of today's Annual General Meeting

11.04.24EQS GroupMedacta announces the 10th M.O.R.E. International Symposium in Lugano, Switzerland, celebrating its 25th anniversary worldwide

09.04.24EQS GroupMedacta publishes 2024 Annual General Meeting invitation

13.03.24EQS GroupMedacta Group SA: Medacta Group SA reports robust revenue growth of 19.5% at constant currency and adjusted EBITDA1 margin 26.3%, or 27.9% at constant currency in FY 2023

12.02.24EQS GroupMedacta to Feature GMK SpheriKA and Innovative Personalized Solutions at AAOS 2024

02.02.24EQS GroupMedacta Group SA: Medacta Group SA revenues up +19.5% at constant currency1 exceeding the milestone of 500Mln € in FY 2023

08.01.24EQS GroupMedacta’s QUADRA-H hip stem achieves 13A* exemplary quality rating from the British Orthopaedic Data Evaluation Panel (ODEP)

14.12.23EQS GroupA new clinical study highlights efficiency in spine surgery of NextAR Spine, augmented reality surgical application

29.11.23EQS GroupMedacta further expands in Rancate, Switzerland, doubling its production capability to support the future growth

30.10.23EQS GroupMedacta Announces the Launch of GMK SpheriKA, the World's First Knee Implant Optimized for Kinematic Alignment (KA)

12.10.23EQS GroupA new study conﬁrms the accuracy of NextAR Shoulder, Medacta’s augmented reality surgical application

22.09.23EQS GroupMedacta Group SA reports strong revenue growth at 21.4% at constant currency and adjusted EBITDA margin at 28.2% in the first semester 2023

28.07.23EQS GroupMedacta Group SA: 2023 Half-Year Unaudited Top-Line Figures

04.07.23EQS GroupMedacta is pleased to announce the first European Peri-Acetabular Osteotomy procedures using the MyPAO Platform, a unique solution for acetabular realignment

03.05.23EQS GroupMedacta showcases NextAR Spine MIS LT procedure at Spine Week, efficiently complementing operative workflow for spine surgery

27.04.23EQS GroupMedacta Group SA: Medacta announces the results of today's Annual General Meeting

19.04.23EQS GroupMedactas P-Family Hip System offering is now more complete with the introduction of the new SMS Collared Stem

05.04.23EQS GroupMedacta Celebrates Expansion into New Distribution Facility in the US

29.03.23EQS GroupMedacta publishes 2023 Annual General Meeting invitation

20.03.23EQS GroupNew clinical study demonstrates Medactas MySpine accuracy in screw replacement during spine revision surgery

17.03.23EQS GroupMedacta Group SA: 2022 Full Year Results

07.03.23EQS GroupMedacta to Showcase MyKA Kinematic Alignment Platform and NextAR Augmented Reality Surgical Platform at AAOS 2023

03.02.23EQS GroupMedacta Group SA: 2022 Full Year Unaudited Top-Line Figures release / Today's call at 4:00pm CET

10.01.23EQS GroupMedacta Group SA: First NextAR surgeries in Japan with the award-winning NextAR Augmented Reality Surgical Platform

Medacta News

Medacta News: auf dieser Seite finden Sie alle Medacta News und Nachrichten zur Medacta Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Medacta News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Medacta News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.